An oncologist's friend: How Xenopus contributes to cancer research

Developmental Biology

Volumn 408, Issue 2, 2015, Pages 180-187

  Hardwick, Laura J A ^a   Philpott, Anna ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cancer; Model; Oncogenesis; Tumour; Xenopus

Indexed keywords

WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER RESEARCH; CARCINOGENESIS; CELL CYCLE; CELL FUNCTION; CELL METABOLISM; EMBRYO DEVELOPMENT; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; LIVER CELL CARCINOMA; LYMPHOSARCOMA; METABOLISM; METASTASIS; NONHUMAN; ONCOGENE; OOCYTE; OVARY TUMOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TERATOMA; THYMUS LYMPHOMA; TUMOR GROWTH; TUMOR RESISTANCE; XENOPUS; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; EMBRYOLOGY; FEMALE; GENETIC EPIGENESIS; GENETICS; HUMAN; MOUSE; NEOPLASMS; ONCOLOGY; TRANSLATIONAL RESEARCH;

ANIMALS; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MEDICAL ONCOLOGY; MICE; MODELS, BIOLOGICAL; NEOPLASMS; ONCOGENES; OOCYTES; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH; XENOPUS;

EID: 84955418971     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2015.02.003     Document Type: Article

References (129)

1. Acloque H., Adams M.S., Fishwick K., Bronner-Fraser M., Nieto M.A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J.Clin. Investig. 2009, 119:1438-1449.
2. Acloque H., Thiery J.P., Nieto M.A. EMBO Rep. The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition 2008, 9:322-326.
3. Ali F., Hindley C., McDowell G., Deibler R., Jones A., Kirschner M., Guillemot F., Philpott A. Cell cycle-regulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis. Development 2011, 138:4267-4277.
4. Ali F.R., Cheng K., Kirwan P., Metcalfe S., Livesey F.J., Barker R.A., Philpott A. The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro. Development 2014, 141:2216-2224.
5. Allegrucci C., Rushton M.D., Dixon J.E., Sottile V., Shah M., Kumari R., Watson S., Alberio R., Johnson A.D. Epigenetic reprogramming of breast cancer cells with oocyte extracts. Mol. Cancer 2011, 10:7.
6. Anderson C.M., Jevons M., Thangaraju M., Edwards N., Conlon N.J., Woods S., Ganapathy V., Thwaites D.T. Transport of the photodynamic therapy agent 5-aminolevulinic acid by distinct H+-coupled nutrient carriers coexpressed in the small intestine. J. Pharmacol. Exp. Ther. 2010, 332:220-228.
7. Asfari M. Mycobacterium-induced infectious granuloma in Xenopus: histopathology and transmissibility. Cancer Res. 1988, 48:958-963.
8. Asfari M., Thiebaud C.H. Transplantation studies of a putative lymphosarcoma of Xenopus. Cancer Res. 1988, 48:954-957.
9. Bailey J.M., Singh P.K., Hollingsworth M.A. Cancer metastasis facilitated by developmental pathways: sonic hedgehog, Notch, and bone morphogenic proteins. J. Cell. Biochem 2007, 102:829-839.
10. Balls M. Lymphosarcoma in the South African clawed toad, Xenopus laevis: a virus tumor. Ann. N. Y. Acad. Sci. 1965, 126:256-273.
11. Berry T., Luther W., Bhatnagar N., Jamin Y., Poon E., Sanda T., Pei D., Sharma B., Vetharoy W.R., Hallsworth A., Ahmad Z., Barker K., Moreau L., Webber H., Wang W., Liu Q., Perez-Atayde A., Rodig S., Cheung N.K., Raynaud F., Hallberg B., Robinson S.P., Gray N.S., Pearson A.D., Eccles S.A., Chesler L., George R.E. The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer Cell 22 2012, 117-130.
12. Berthet C., Aleem E., Coppola V., Tessarollo L., Kaldis P. Cdk2 knockout mice are viable. Curr. Biol. 2003, 13:1775-1785.
13. Bian Y., Alberio R., Allegrucci C., Campbell K.H., Johnson A.D. Epigenetic marks in somatic chromatin are remodelled to resemble pluripotent nuclei by amphibian oocyte extracts. Epigenet. Off. J. DNA Methylation Soc. 2009, 4:194-202.
14. Blow J.J. Control of chromosomal DNA replication in the early Xenopus embryo. EMBO J. 2001, 20:3293-3297.
15. Blow J.J., Laskey R.A. Initiation of DNA replication in nuclei and purified DNA by a cell-free extract of Xenopus eggs. Cell 1986, 47:577-587.
16. Browaeys-Poly E., Perdereau D., Lescuyer A., Burnol A.F., Cailliau K. Akt interaction with PLC(gamma) regulates the G(2)/M transition triggered by FGF receptors from MDA-MB-231 breast cancer cells. Anticancer Res. 2009, 29:4965-4969.
17. Bui J.D., Schreiber R.D. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?. Curr. Opin. Immunol. 2007, 19:203-208.
18. Cailliau K., Perdereau D., Lescuyer A., Chen H., Garbay C., Vilain J.P., Burnol A.F., Browaeys-Poly E. FGF receptor phosphotyrosine 766 is a target for Grb14 to inhibit MDA-MB-231 human breast cancer cell signaling. Anticancer Res. 2005, 25:3877-3882.
19. Carruthers S., Mason J., Papalopulu N. Depletion of the cell-cycle inhibitor p27(Xic1) impairs neuronal differentiation and increases the number of ElrC(+) progenitor cells in Xenopus tropicalis. Mech. Dev. 2003, 120:607-616.
20. Cekanova M., Rathore K. Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des. Dev. Ther. 2014, 8:1911-1921.
21. Cha S.W., Heasman J. Using oocytes for Wnt signaling assays: paracrine assays and Wnt-conditioned medium. Methods 2010, 51:52-55.
22. Cheong S.W., Fukui A., Asashima M., Pfeiffer C.J. Spontaneous thyroid-containing teratoma associated with impaired development in the African clawed frog, Xenopus laevis. J. Comp. Pathol. 2000, 123:110-118.
23. Chernet B.T., Levin M. Transmembrane voltage potential of somatic cells controls oncogene-mediated tumorigenesis at long-range. Oncotarget 2014, 5:3287-3306.
24. Cross M.K., Powers M.A. Learning about cancer from frogs: analysis of mitotic spindles in Xenopus egg extracts. Dis. Models Mech. 2009, 2:541-547.
25. Dahmane N., Lee J., Robins P., Heller P., Ruiz i Altaba A. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 1997, 389:876-881.
26. de Robertis A., Valensin S., Rossi M., Tunici P., Verani M., De Rosa A., Giordano C., Varrone M., Nencini A., Pratelli C., Benicchi T., Bakker A., Hill J., Sangthongpitag K., Pendharkar V., Liu B., Ng F.M., Then S.W., Jing Tai S., Cheong S.M., He X., Caricasole A., Salerno M. Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells. Mol. Cancer Ther. 2013, 12:1180-1189.
27. Deming P., Kornbluth S. Study of apoptosis in vitro using the Xenopus egg extract reconstitution system. Methods Mol. Biol. 2006, 322:379-393.
28. Desai A., Murray A., Mitchison T.J., Walczak C.E. The use of Xenopus egg extracts to study mitotic spindle assembly and function in vitro. Methods Cell Biol. 1999, 61:385-412.
29. Dikovskaya D., Khoudoli G., Newton I.P., Chadha G.S., Klotz D., Visvanathan A., Lamond A., Swedlow J.R., Nathke I.S. The adenomatous polyposis coli protein contributes to normal compaction of mitotic chromatin. PloS One 2012, 7:e38102.
30. du Pasquier L., Robert J. In vitro growth of thymic tumor cell lines from Xenopus. Dev. Immunol. 1992, 2:295-307.
31. Dworkin M.B., Dworkin-Rastl E. Metabolic regulation during early frog development: glycogenic flux in Xenopus oocytes, eggs, and embryos. Dev. Biol. 1989, 132:512-523.
32. Earley E.M., Reinschmidt D.C., Tompkins R., Gebhardt B.M. Tissue culture of a mixed cell thymic tumor from Xenopus laevis. In vitro cellular and developmental biology. Animal 1995, 31:255-257.
33. Felix M.A., Labbe J.C., Doree M., Hunt T., Karsenti E. Triggering of cyclin degradation in interphase extracts of amphibian eggs by cdc2 kinase. Nature 1990, 346:379-382.
34. Felix M.A., Pines J., Hunt T., Karsenti E. A post-ribosomal supernatant from activated Xenopus eggs that displays post-translationally regulated oscillation of its cdc2+ mitotic kinase activity. EMBO J 1989, 8:3059-3069.
35. Glackin C.A. Targeting the Twist and Wnt signaling pathways in metastatic breast cancer. Maturitas 2014, 79:48-51.
36. Goding C.R., Pei D., Lu X. Cancer: pathological nuclear reprogramming? Nature reviews. Cancer 2014, 14:568-573.
37. Goyos A., Robert J. Tumorigenesis and anti-tumor immune responses in Xenopus. Front. Biosci. (Landmark edition) 2009, 14:167-176.
38. Gradl D., Kuhl M., Wedlich D. Keeping a close eye on Wnt-1/wg signaling in Xenopus. Mech. Dev. 1999, 86:3-15.
39. Gurdon J.B., Elsdale T.R., Fischberg M. Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 1958, 182:64-65.
40. Halley-Stott R.P., Gurdon J.B. Epigenetic memory in the context of nuclear reprogramming and cancer. Brief. Funct. Genomics 2013, 12:164-173.
41. Halley-Stott R.P., Pasque V., Gurdon J.B. Nuclear reprogramming. Development 2013, 140:2468-2471.
42. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
43. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
44. Hardwick L.J., Philpott A. Nervous decision-making: to divide or differentiate. Trends Genet. 2014, 30:254-261.
45. Harper J.V., Brooks G. The mammalian cell cycle: an overview. Methods Mol. Biol. 2005, 296:113-153.
46. Hashimoto Y., Costanzo V. Studying DNA replication fork stability in Xenopus egg extract. Methods Mol. Biol. 2011, 745:437-445.
47. Haynes-Gilmore N., Banach M., Edholm E.S., Lord E., Robert J. A critical role of non-classical MHC in tumor immune evasion in the amphibian Xenopus model. Carcinogenesis 2014, 35:1807-1813.
48. Hikasa H., Sokol S.Y. Wnt signaling in vertebrate axis specification. Cold Spring Harb. Perspect. Biol. 2013, 5:a007955.
49. Hindley C., Ali F., McDowell G., Cheng K., Jones A., Guillemot F., Philpott A. Post-translational modification of Ngn2 differentially affects transcription of distinct targets to regulate the balance between progenitor maintenance and differentiation. Development 2012, 139:1718-1723.
50. Hingorani S.R., Wang L., Multani A.S., Combs C., Deramaudt T.B., Hruban R.H., Rustgi A.K., Chang S., Tuveson D.A. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005, 7:469-483.
51. Ishimura A., Lee H.S., Bong Y.S., Saucier C., Mood K., Park E.K., Daar I.O. Oncogenic Met receptor induces ectopic structures in Xenopus embryos. Oncogene 2006, 25:4286-4299.
52. Joukov V., Groen A.C., Prokhorova T., Gerson R., White E., Rodriguez A., Walter J.C., Livingston D.M. The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly. Cell 2006, 127:539-552.
53. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009, 119:1420-1428.
54. Kuhl M. Non-canonical Wnt signaling in Xenopus: regulation of axis formation and gastrulation. Semin. Cell Dev. Biol. 2002, 13:243-249.
55. Kuhl M., Pandur P. Dorsal axis duplication as a functional readout for Wnt activity. Methods Mol. Biol. 2008, 469:467-476.
56. Kuhl M., Pandur P. Measuring CamKII activity in Xenopus embryos as a read-out for non-canonical Wnt signaling. Methods Mol. Biol. 2008, 468:173-186.
57. Kvist T., Hansen K.B., Brauner-Osborne H. The use of Xenopus oocytes in drug screening. Expert Opin. Drug Discov. 2011, 6:141-153.
58. Laiho M., Latonen L. Cell cycle control, DNA damage checkpoints and cancer. Ann. Med. 2003, 35:391-397.
59. Landais I., Sobeck A., Stone S., la Chapelle A., Hoatlin M.E. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway. Int. J. Cancer/J. Int. Cancer 2009, 124:783-792.
60. Lander R., Nasr T., Ochoa S.D., Nordin K., Prasad M.S., Labonne C. Interactions between Twist and other core epithelial-mesenchymal transition factors are controlled by GSK3-mediated phosphorylation. Nat. Commun. 2013, 4:1542.
61. Laskey R.A., Honda B.M., Mills A.D., Morris N.R., Wyllie A.H., Mertz J.E., De Roberts E.M., Gurdon J.B. Chromatin assembly and transcription in eggs and oocytes of Xenopus laevis. Cold Spring Harb. Symp. Quant. Biol. 1978, 42(Pt 1):171-178.
62. Leno G.H., Downes C.S., Laskey R.A. The nuclear membrane prevents replication of human G2 nuclei but not G1 nuclei in Xenopus egg extract. Cell 1992, 69:151-158.
63. Leno G.H., Laskey R.A. DNA replication in cell-free extracts from Xenopus laevis. Methods Cell Biol. 1991, 36:561-579.
64. Liu D., Rudland P.S., Sibson D.R., Platt-Higgins A., Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res. 2005, 65:3796-3805.
65. Liu X., Chang Y., Reinhart P.H., Sontheimer H., Chang Y. Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J. Neurosci. Off. J. Soc. Neurosci. 2002, 22:1840-1849.
66. Lujan E., Wernig M. The many roads to Rome: induction of neural precursor cells from fibroblasts. Curr. Opin. Genet. Dev. 2012, 22:517-522.
67. Ma Y., Zhang P., Wang F., Yang J., Yang Z., Qin H. The relationship between early embryo development and tumourigenesis. J. Cell. Mol. Med. 2010, 14:2697-2701.
68. Mani S.A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., Kutok J.L., Hartwell K., Richardson A.L., Weinberg R.A. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. USA 2007, 104:10069-10074.
69. McDowell G.S., Hardwick L.J., Philpott A. Complex domain interactions regulate stability and activity of closely related proneural transcription factors. Biochem. Biophys. Res. Commun. 2014, 450:1283-1290.
70. Mimori-Kiyosue Y., Matsui C., Sasaki H., Tsukita S. Adenomatous polyposis coli (APC) protein regulates epithelial cell migration and morphogenesis via PDZ domain-based interactions with plasma membranes. Genes Cells: Devot. Mol Cell Mech 2007, 12:219-233.
71. Minshull J., Golsteyn R., Hill C.S., Hunt T. The A- and B-type cyclin associated cdc2 kinases in Xenopus turn on and off at different times in the cell cycle. EMBO J. 1990, 9:2865-2875.
72. Miyata S., Wang L.Y., Wang N.L., Yao X.S., Kitanaka S. Selective inhibition of the growth of cancer cells by diterpenes selected with embryonic cells of Xenopus. Cell Biol. Int. 2004, 28:179-184.
73. Nakaya Y., Sheng G. EMT in developmental morphogenesis. Cancer Lett. 2013, 341:9-15.
74. Newport J., Kirschner M. A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage. Cell 1982, 30:675-686.
75. Newport J., Kirschner M. A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription. Cell 1982, 30:687-696.
76. Nutt L.K. The Xenopus oocyte: a model for studying the metabolic regulation of cancer cell death. Semin. Cell Dev. Biol. 2012, 23:412-418.
77. Ny A., Koch M., Schneider M., Neven E., Tong R.T., Maity S., Fischer C., Plaisance S., Lambrechts D., Heligon C., Terclavers S., Ciesiolka M., Kalin R., Man W.Y., Senn I., Wyns S., Lupu F., Brandli A., Vleminckx K., Collen D., Dewerchin M., Conway E.M., Moons L., Jain R.K., Carmeliet P. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat. Med. 2005, 11:998-1004.
78. Ny A., Vandevelde W., Hohensinner P., Beerens M., Geudens I., Diez-Juan A., Brepoels K., Plaisance S., Krieg P.A., Langenberg T., Vinckier S., Luttun A., Carmeliet P., Dewerchin M. A transgenic Xenopus laevis reporter model to study lymphangiogenesis. Biol. Open 2013, 2:882-890.
79. Okudaira H., Nakanishi T., Oka S., Kobayashi M., Tamagami H., Schuster D.M., Goodman M.M., Shirakami Y., Tamai I., Kawai K. Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2. Nucl. Med. Biol. 2013, 40:670-675.
80. Ortega S., Prieto I., Odajima J., Martin A., Dubus P., Sotillo R., Barbero J.L., Malumbres M., Barbacid M. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 2003, 35:25-31.
81. Pakladok T., Hosseinzadeh Z., Alesutan I., Lang F. Stimulation of the Na(+)-coupled glucose transporter SGLT1 by B-RAF. Biochem. Biophys. Res. Commun. 2012, 427:689-693.
82. Pakladok T., Hosseinzadeh Z., Almilaji A., Lebedeva A., Shumilina E., Alesutan I., Lang F. Up-regulation of hERG K(+) channels by B-RAF. PloS One 2014, 9:e87457.
83. Pennisi E. How a growth control path takes a wrong turn to cancer. Science 1998, 281(1438-1439):1441.
84. Philpott A., Yew P.R. The Xenopus cell cycle: an overview. Mol. Biotechnol. 2008, 39:9-19.
85. Rane S.G., Dubus P., Mettus R.V., Galbreath E.J., Boden G., Reddy E.P., Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet. 1999, 22:44-52.
86. Richard-Parpaillon L., Cosgrove R.A., Devine C., Vernon A.E., Philpott A. G1/S phase cyclin-dependent kinase overexpression perturbs early development and delays tissue-specific differentiation in Xenopus. Development 2004, 131:2577-2586.
87. Robert J. Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates. Dev. Comp. Immunol. 2010, 34:915-925.
88. Robert J., Cohen N. Evolution of immune surveillance and tumor immunity: studies in Xenopus. Immunol. Rev. 1998, 166:231-243.
89. Robert J., Guiet C., Cohen N., du Pasquier L. Effects of thymectomy and tolerance induction on tumor immunity in adult Xenopus laevis. Int. J. Cancer/J. Int. Cancer 1997, 70:330-334.
90. Robert J., Guiet C., Du Pasquier L. Lymphoid tumors of Xenopus laevis with different capacities for growth in larvae and adults. Dev. Immunol. 1994, 3:297-307.
91. Rosania G.R., Merlie J., Gray N., Chang Y.T., Schultz P.G., Heald R. A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts. Proc. Natl. Acad. Sci.USA 1999, 96:4797-4802.
92. Ruben L.N., Clothier R.H., Balls M. Cancer resistance in amphibians. Altern. Lab. Anim. 2007, 35:463-470.
93. Sadikovic B., Al-Romaih K., Squire J.A., Zielenska M. Cause and consequences of genetic and epigenetic alterations in human cancer. Curr. Genomics 2008, 9:394-408.
94. Saka Y., Smith J.C. Spatial and temporal patterns of cell division during early Xenopus embryogenesis. Dev. Biol. 2001, 229:307-318.
95. Santamaria D., Ortega S. Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front. Biosci. J. Virtual Libr. 2006, 11:1164-1188.
96. Schmitt S.M., Gull M., Brandli A.W. Engineering Xenopus embryos for phenotypic drug discovery screening. Adv. Drug Deliv. Rev. 2014, 69-70:225-246.
97. Srinivasan S.V., Gautier J. Study of cell cycle checkpoints using Xenopus cell-free extracts. Methods Mol. Biol. 2011, 782:119-158.
98. Taube J.H., Herschkowitz J.I., Komurov K., Zhou A.Y., Gupta S., Yang J., Hartwell K., Onder T.T., Gupta P.B., Evans K.W., Hollier B.G., Ram P.T., Lander E.S., Rosen J.M., Weinberg R.A., Mani S.A. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. USA 2010, 107:15449-15454.
99. Theveneau E., Mayor R. Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration. Dev. Biol. 2012, 366:34-54.
100. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
101. Tsutsui T., Hesabi B., Moons D.S., Pandolfi P.P., Hansel K.S., Koff A., Kiyokawa H. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol. Cell. Biol. 1999, 19:7011-7019.
102. Tumova L., Pombinho A.R., Vojtechova M., Stancikova J., Gradl D., Krausova M., Sloncova E., Horazna M., Kriz V., Machonova O., Jindrich J., Zdrahal Z., Bartunek P., Korinek V. Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice. Mol. Cancer Ther. 2014, 13:812-822.
103. Ureta T., Preller A., Kessi E. Frog oocytes: a living test tube for studies on metabolic regulation. IUBMB Life 2001, 51:5-10.
104. Vernon A.E. The cdk inhibitor p27Xic1 is required for differentiation of primary neurones in Xenopus. Development 2003, 130:85-92.
105. Vernon A.E., Devine C., Philpott A. The cdk inhibitor p27Xic1 is required for differentiation of primary neurones in Xenopus. Development 2003, 130:85-92.
106. Vernon A.E., la Bonne C. Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr. Biol. 2004, 14:R719-721.
107. Vernon A.E., Movassagh M., Horan I., Wise H., Ohnuma S., Philpott A. Notch targets the Cdk inhibitor Xic1 to regulate differentiation but not the cell cycle in neurons. EMBO Rep. 2006, 7:643-648.
108. Vernon A.E., Philpott A. A single cdk inhibitor, p27Xic1, functions beyond cell cycle regulation to promote muscle differentiation in Xenopus. Development 2003, 130:71-83.
109. Vosper J.M., McDowell G.S., Hindley C.J., Fiore-Heriche C.S., Kucerova R., Horan I., Philpott A. Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis. J. Biol. Chem. 2009, 284:15458-15468.
110. Waaler J., Machon O., Tumova L., Dinh H., Korinek V., Wilson S.R., Paulsen J.E., Pedersen N.M., Eide T.J., Machonova O., Gradl D., Voronkov A., von Kries J.P., Krauss S. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Cancer Res. 2012, 72:2822-2832.
111. Waaler J., Machon O., von Kries J.P., Wilson S.R., Lundenes E., Wedlich D., Gradl D., Paulsen J.E., Machonova O., Dembinski J.L., Dinh H., Krauss S. Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 2011, 71:197-205.
112. Wallingford J.B. Tumors in tadpoles: the Xenopus embryo as a model system for the study of tumorigenesis. Trends Genet: TIG 1999, 15:385-388.
113. Wallingford J.B., Seufert D.W., Virta V.C., Vize P.D. p53 activity is essential for normal development in Xenopus. Curr. Biol. 1997, 7:747-757.
114. Wang Y. Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol. Cancer Ther. 2009, 8:2103-2109.
115. Wang Z., Gao H., Wang H., Ren X., Bao L., Sa R., Wang J., Bai H., Yu H. Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract. Oncol. Rep. 2013, 30:179-184.
116. Wang Z., Yue Y., Han P., Sa R., Ren X., Wang J., Bai H., Yu H. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract. Cytotherapy 2013, 15:1164-1173.
117. Wei X., Sun H., Yan H., Zhang C., Zhang S., Liu X., Hua N., Ma X., Zheng J. ZC88, a novel 4-amino piperidine analog, inhibits the growth of neuroblastoma cells through blocking hERG potassium channel. Cancer Biol. Ther. 2013, 14:450-457.
118. Whitman M., Melton D.A. Involvement of p21ras in Xenopus mesoderm induction. Nature 1992, 357:252-254.
119. Willis J., de Stephanis D., Patel Y., Gowda V., Yan S. Study of the DNA damage checkpoint using Xenopus egg extracts. J. Vis. Exp. 2012, e4449.
120. Woodland H.R. Some studies on early embryonic development relevant to the study of cancer. J. Clin. Pathol. 1974, 7:S26-S30.
121. Wu F., Stutzman A., Mo Y.Y. Notch signaling and its role in breast cancer. Front. Biosci. J. Virtual Libr. 2007, 12:4370-4383.
122. Wu X., Gao H., Ke W., Hager M., Xiao S., Freeman M.R., Zhu Z. VentX trans-activates p53 and p16ink4a to regulate cellular senescence. J. Biol. Chem. 2011, 286:12693-12701.
123. Xi Y., Chen Y. Wnt signaling pathway: implications for therapy in lung cancer and bone metastasis. Cancer Lett. 2014, 353:8-16.
124. Xie K., Abbruzzese J.L. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell 2003, 4:245-247.
125. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
126. Yang S., Lockwood A., Hollett P., Ford R., Kao K. Overexpression of a novel Xenopus Rel mRNA Gene induces tumors in early embryos. J. Biol. Chem. 1998, 273:13746-13752.
127. Yew P.R., Kirschner M.W. Proteolysis and DNA replication: the CDC34 requirement in the Xenopus egg cell cycle. Science 1997, 277:1672-1676.
128. You Z., Bailis J.M., Johnson S.A., Dilworth S.M., Hunter T. Rapid activation of ATM on DNA flanking double-strand breaks. Nat. Cell Biol. 2007, 9:1311-1318.
129. Zylkiewicz E., Stukenberg P.T. Xenopus egg extracts as a simplified model system for structure-function studies of dynein regulators. Methods Mol. Biol. 2014, 1136:117-133.